Biotech can’t continue to innovate under strain of Big Pharma market pressures
Biotechnology is one of the United States’ defining strengths. It produces most new medicines, translates discovery into survival and sits at the center of modern healthcare. Yet the system that supports it is under strain, as it was never built for what …